Stephen Ma - Scilex Holding Senior CFO
| SCLX Stock | 0.52 0.03 5.45% |
CFO
Stephen Ma is Senior CFO of Scilex Holding
| Age | 51 |
| Address | 960 San Antonio Road, Palo Alto, CA, United States, 94303 |
| Phone | 650 516 4310 |
| Web | https://www.scilexholding.com |
Stephen Ma Latest Insider Activity
Tracking and analyzing the buying and selling activities of Stephen Ma against Scilex Holding stock is an integral part of due diligence when investing in Scilex Holding. Stephen Ma insider activity provides valuable insight into whether Scilex Holding is net buyers or sellers over its current business cycle. Note, Scilex Holding insiders must abide by specific rules, including filing SEC forms every time they buy or sell Scilex Holding'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Stephen Ma over three months ago Disposition of 67349 shares by Stephen Ma of Scilex Holding at 1.73 subject to Rule 16b-3 | ||
Stephen Ma over six months ago Disposition of 67349 shares by Stephen Ma of Scilex Holding at 1.73 subject to Rule 16b-3 |
Scilex Holding Management Efficiency
The company has return on total asset (ROA) of (0.5364) % which means that it has lost $0.5364 on every $100 spent on assets. This is way below average. Scilex Holding's management efficiency ratios could be used to measure how well Scilex Holding manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Scilex Holding's Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to rise to 0.69 in 2024, whereas Return On Tangible Assets are likely to drop (2.34) in 2024. At this time, Scilex Holding's Intangibles To Total Assets are fairly stable compared to the past year. Debt To Assets is likely to rise to 1.34 in 2024, whereas Total Assets are likely to drop slightly above 95.5 M in 2024.Similar Executives
| Found 5 records | CFO Age | ||
| Scott Reents | AbbVie Inc | 56 | |
| Michael CPA | Biogen Inc | 60 | |
| Peter Griffith | Amgen Inc | 65 | |
| Lucas Montarce | Eli Lilly and | 47 | |
| Harry Kirsch | Novartis AG ADR | 59 | |
Management Performance
| Return On Asset | -0.54 |
Scilex Holding Leadership Team
Elected by the shareholders, the Scilex Holding's board of directors comprises two types of representatives: Scilex Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Scilex. The board's role is to monitor Scilex Holding's management team and ensure that shareholders' interests are well served. Scilex Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Scilex Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stephen Ma, Senior CFO | ||
| Mike Ciaffi, National Director | ||
| Steven JD, Interim Officer | ||
| Jaisim Shah, CEO President | ||
| Gigi DeGuzman, Executive Resources | ||
| Dmitri MD, Senior Officer | ||
| Sumant Rajendran, Executive Marketing | ||
| Henry Ji, Executive Chairman | ||
| Elizabeth MBA, CFO, VP | ||
| Suketu Desai, Chief Officer | ||
| Suresh Khemani, Senior Officer | ||
| Elaine Chan, Executive Affairs |
Scilex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Scilex Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.54 | ||||
| Profit Margin | (2.34) % | ||||
| Operating Margin | (0.95) % | ||||
| Current Valuation | 169.85 M | ||||
| Shares Outstanding | 133.92 M | ||||
| Shares Owned By Insiders | 32.78 % | ||||
| Shares Owned By Institutions | 18.16 % | ||||
| Number Of Shares Shorted | 11.04 M | ||||
| Price To Book | 28.85 X | ||||
| Price To Sales | 1.37 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Scilex Stock Analysis
When running Scilex Holding's price analysis, check to measure Scilex Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scilex Holding is operating at the current time. Most of Scilex Holding's value examination focuses on studying past and present price action to predict the probability of Scilex Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scilex Holding's price. Additionally, you may evaluate how the addition of Scilex Holding to your portfolios can decrease your overall portfolio volatility.